Tomoyoshi Soga

Keio University — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

84h-index34.4kcitations695works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metabolomics and Mass Spectrometry Studies(166), Cancer, Hypoxia, and Metabolism(115), RNA modifications and cancer(62), Cancer Immunotherapy and Biomarkers(53), Diet and metabolism studies(48)

Publications694 total

Cross-sectional associations between CES-D scores and the salivary metabolome in nonclinical adults
Discover Mental Health·2026Open Access
Abrogation of aberrant glycolytic interactions eliminates senescent cells and alleviates aging-related dysfunctions
Signal Transduction and Targeted Therapy·2025Open Access
Longitudinal Study of Plasma Metabolites During Menopause and Their Associations With Later Onset of Metabolic Syndrome
The Journal of Clinical Endocrinology & Metabolism·2025Open Access
The Gibbs free energy landscape based on liver metabolome revealed thermodynamic robustness against fasting and obesity
2025Open Access
Context‐Specific Metabolic Alterations in HPRT1 Knockout Cells Within a 3D Culture System
Cancer Medicine·2025Open Access
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells
Blood·2025· 1 citedOpen Access
Multi-modal profiling and targeting of the tumor microenvironment in central nervous system lymphoma
Blood·2025Open Access
Identification of Gut Microbiota Modulating Kidney Function in CKD
Journal of the American Society of Nephrology·2025
Data from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Figure S12 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Figure S3 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Figure S1 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Table S1 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Figure S7 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Figure S4 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Figure S5 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Figure S11 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Figure S6 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Figure S9 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
Supplementary Figure S10 from EML4–ALK Rearrangement Creates a Distinctive Myeloid Cell–Dominant Immunosuppressive Microenvironment in Lung Cancer
2025Open Access
page 1 of 35Next →

Frequent Co-authors

Masaru Tomita(19), Masahiro Sugimoto(10), Akiyoshi Hirayama(10), Makoto Suematsu(8), Takaaki Nishi­oka(7), Shinji Fukuda(5), Patrick J. Pollard(5), Kaori Igarashi(5), Yuji Kakazu(4), Yoshiaki Ohashi(4), Yuki Ueno(4), Satsuki Ikeda(4), Takamasa Ishikawa(4), Martin Robert(4), Julie Adam(4), Takehiro Suzuki(4), Eikan Mishima(4), Yasutoshi Akiyama(4), Sadayoshi Ito(4), Takaaki Abe(4)